Risks and Benefits of Long-Term Use of Nicotine Replacement Therapy Products: Public Workshops; Request for Comments
Document ID: FDA-2010-N-0449-0001
Comments
Total: 8
-
William P George - Comment
Posted : 09/24/2010 ID :FDA-2010-N-0449-0002 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
GlaxoSmithKline Consumer Healthcare - Comment
Posted : 10/25/2010 ID :FDA-2010-N-0449-0003 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
GlaxoSmithKline CH + McNeil CH - Comment
Posted : 10/25/2010 ID :FDA-2010-N-0449-0004 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
Scott D. Ballin, JD - Comment
Posted : 11/10/2010 ID :FDA-2010-N-0449-0005 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
Tiffanie Leistner - Comment
Posted : 11/10/2010 ID :FDA-2010-N-0449-0006 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
Logan Brinkerhoff Wrigley - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0449-0007 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
American Academy of Pediatrics - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0449-0008 Agency : FDA -
Dec 27,2010 11:59 PM ET
-
David Sweanor - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0449-0009 Agency : FDA -
Dec 27,2010 11:59 PM ET